Fox Run Management, L.L.C. Exact Sciences Corp Transaction History

Fox Run Management, L.L.C.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$90.24 - $124.05 $361,772 - $497,316	-4,009 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$93.66 - $139.27 $375,482 - $558,333	4,009 New	4,009 $498,000
Q3 2020 Oct 29, 2020	SELL	$72.92 - $102.01 $507,887 - $710,499	-6,965 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$55.75 - $92.75 $388,298 - $646,003	6,965 New	6,965 $606,000
Q4 2019 Feb 14, 2020	SELL	$77.66 - $99.74 $249,599 - $320,564	-3,214 Closed	0 $0
Q3 2019 Oct 15, 2019	BUY	$90.37 - $122.49 $290,449 - $393,682	3,214 New	3,214 $290,000
Q1 2019 Oct 17, 2019	SELL	$61.98 - $96.5 $280,831 - $437,241	-4,531 Closed	0 $0
Q4 2018 Jan 15, 2019	BUY	$56.04 - $82.66 $253,917 - $374,532	4,531 New	4,531 $286,000
Q3 2018 Oct 05, 2018	SELL	$48.29 - $80.6 $532,010 - $887,970	-11,017 Closed	0 $0
Q2 2018 Jul 17, 2018	BUY	$37.84 - $69.96 $416,883 - $770,749	11,017 New	11,017 $659,000

676

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.1B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.